Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 11;30(3):3232-3250.
doi: 10.3390/curroncol30030246.

Anal Cancer: The Past, Present and Future

Affiliations
Review

Anal Cancer: The Past, Present and Future

Talha Ashraf Gondal et al. Curr Oncol. .

Abstract

Anal cancer is a rare cancer that accounts for about 2% of all gastrointestinal tract malignancies. Among anal cancer, squamous cell cancer is the most common malignancy. The incidence of all stages of anal squamous cell cancer has been increasing. Human papillomavirus infection and immunosuppression are major risk factors for anal cancer. The management of anal cancer has evolved over the past several decades and continues to do so. Chemoradiation therapy remains the mainstay for treatment for most patients with early-stage disease, whereas systemic therapy is the primary treatment for patients with metastatic disease. Patients with persistent disease or recurrence following chemoradiation therapy are treated with salvage surgery. Access to novel cytotoxic combinations and immunotherapy has improved the outcomes of patients with advanced disease. This review provides an overview of advances in the management of anal cancer over the past two decades. This paper reviews the epidemiology, risk factors, pathology, diagnosis, and management of localized and advanced anal squamous cell cancer, highlights current knowledge gaps in the management of anal cancer, and discusses future directions.

Keywords: Anal cancer; anal canal cancer; chemotherapy; human papilloma virus; radiation; squamous cell anal cancer; surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Treatment algorithm of localized and advanced anal cancer. APR = abdominoperineal resection; CRT = chemoradiation therapy.

References

    1. National Cancer Institute: Surveillance, Epidemiology, and End Results Program Cancer Stat Facts: Anal Cancer. [(accessed on 10 March 2023)]; Available online: https://seer.cancer.gov/statfacts/html/anus.html.
    1. Hoff P.M., Coudry R., Moniz C.M.V. Pathology of anal cancer. Surg. Oncol. Clin. North Am. 2017;26:57–71. doi: 10.1016/j.soc.2016.07.013. - DOI - PubMed
    1. Islami F., Ferlay J., Lortet-Tieulent J., Bray F., Jemal A. International trends in anal cancer incidence rates. Int. J. Epidemiol. 2017;46:924–938. doi: 10.1093/ije/dyw276. - DOI - PubMed
    1. American Cancer Society: Cancer Facts and Figures 2023. American Cancer Society, 2023. [(accessed on 5 March 2023)]. Available online: https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-....
    1. Kang Y.J., Smith M., Canfell K. Anal cancer in high-income countries: Increasing burden of disease. PLoS ONE. 2018;13:e0205105. doi: 10.1371/journal.pone.0205105. - DOI - PMC - PubMed

Substances